Pictet Asset Management (UK)’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Pictet Asset Management (UK)’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$48.2M	Sell	422,554 -85,117	-17%	-$9.95M	0.05%	357
2021 Q1	$61M	Sell	507,671 -47,556	-9%	-$5.39M	0.07%	292
2020 Q4	$56.4M	Sell	555,227 -107,890	-16%	-$10M	0.07%	282
2020 Q3	$51.3M	Buy	663,117 +167,253	+34%	+$14.3M	0.08%	270
2020 Q2	$55.3M	Buy	495,864 +149,412	+43%	+$13M	0.1%	241
2020 Q1	$24.9M	Buy	346,452 +47,575	+16%	+$4.07M	0.05%	327
2019 Q4	$22.5M	Buy	298,877 +248,877	+498%	+$10.9M	0.04%	413
2019 Q3	$816K	Buy	+50,000	New	+$972K	﹤0.01%	934

Other funds holding KRTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

PBPIA

Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Pictet Asset Management (UK)'s KRTX Position: Q2 2021 in Review

Pictet Asset Management (UK) reduced its Karuna Therapeutics, Inc. Common Stock (KRTX) stake by 17% in Q2 2021, selling an estimated $9.95M and leaving 422,554 shares worth $48.2M. The position accounts for 0.05% of the portfolio, ranked #357.

Pictet Asset Management (UK) first reported a position in KRTX in Q3 2019 and has held it in 8 quarters since. The position peaked at $61M in Q1 2021. 159 funds tracked by Wall St. Rank hold KRTX as of Q2 2021.

Pictet Asset Management (UK) held 422,554 shares of Karuna Therapeutics, Inc. Common Stock worth $48.2M as of Q2 2021.
Pictet Asset Management (UK) sold 85,117 Karuna Therapeutics, Inc. Common Stock shares in Q2 2021, an estimated $9.95M.
Karuna Therapeutics, Inc. Common Stock made up 0.05% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #357 holding.
Pictet Asset Management (UK) first reported a position in Karuna Therapeutics, Inc. Common Stock in Q3 2019 and has held it in 8 quarters since.
Pictet Asset Management (UK)'s Karuna Therapeutics, Inc. Common Stock position peaked at $61M in Q1 2021.
159 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.